信息编号11344501至11345000间共476条。 >>更多

• 11344501:Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
• 11344502:Estimating Influenza Hospitalizations among Children
• 11344503:SARS–associated Coronavirus Replication in Cell Lines
• 11344504:Ocular Vaccinia Infection in Laboratory Worker, Philadelphia, 2004
• 11344505:Genetic Diversity of Sapovirus in Children, Australia
• 11344506:Influenza, Winter Olympiad, 2002
• 11344507:Novel Human Metapneumovirus Sublineage
• 11344508:Novel Parvovirus and Related Variant in Human Plasma
• 11344509:Coordinated Response to SARS, Vancouver, Canada
• 11344510:Pathogen Transmission and Clinic Scheduling
• 11344511:Histoplasmosis Cluster, Golf Course, Canada
• 11344512:Rickettsia felis Infection, Tunisia
• 11344513:Influenza-associated Deaths in Tropical Singapore
• 11344514:Neutralizing Antibodies in Survivors of Sin Nombre and Andes Hantavirus Infection
• 11344515:New Route of Importation of Mycobacterium tuberculosis Beijing Genotype
• 11344516:Helicobacter pylori and Immunocompromised Children
• 11344517:Community Case of Methicillin-resistant Staphylococcus aureus Infection
• 11344518:Rickettsia massiliae Human Isolation
• 11344519:Bertiella studeri Infection, China
• 11344520:Influenza Revisited
• 11344521:H5N1 Outbreaks and Enzootic Influenza
• 11344522:Influenza Pandemics of the 20th Century
• 11344523:1918 Influenza: the Mother of All Pandemics
• 11344524:Real-time Estimates in Early Detection of SARS
• 11344525:Swine Influenza A Outbreak, Fort Dix, New Jersey, 1976
• 11344526:Reflections on the 1976 Swine Flu Vaccination Program
• 11344527:Influenza Pandemic Periodicity, Virus Recycling, and the Art of Risk Assessment
• 11344528:The Swine Flu Episode and the Fog of Epidemics1
• 11344529:Antiviral Response in Pandemic Influenza Viruses
• 11344530:Cell-mediated Protection in Influenza Infection
• 11344531:Vaccines and Antiviral Drugs in Pandemic Preparedness
• 11344532:Making Better Influenza Virus Vaccines
• 11344533:Vaccines for Pandemic Influenza
• 11344534:Pandemic Influenza Threat and Preparedness1
• 11344535:Real-time Forecast of Multiphase Outbreak
• 11344536:Bartonella quintana in Cynomolgus Monkey(Macaca fascicularis)
• 11344537:Passatempo Virus, a Vaccinia Virus Strain, Brazil
• 11344538:Anthrax in Eastern Turkey, 1992–2004
• 11344539:Hemolytic Uremic Syndrome Risk and Escherichia coli O157:H7
• 11344540:Hepatitis E Virus Transmission from Wild Boar Meat
• 11344541:Echinococcus multilocularis in Estonia
• 11344542:Human Angiostrongylus cantonensis, Jamaica
• 11344543:Influenza Virus Infection in Racing Greyhounds
• 11344544:Syngamoniasis in Tourist
• 11344545:Nipah Virus Strain Variation
• 11344546:Human Rickettsia felis Infection, Canary Islands, Spain
• 11344547:Trichinellosis Outbreak
• 11344548:Vancomycin-resistant Enterococcus faecium Clone in Swine, Europe
• 11344549:Rabies Vaccine Baits, Pennsylvania
• 11344550:Salmonella Typhimurium Veterinary Clinic Outbreak
• 11344551:Role of Multisector Partnerships in Controlling Emerging Zoonotic Diseases
• 11344552:Community Epidemiology Framework for Classifying Disease Threats
• 11344553:Bushmeat Hunting, Deforestation, and Prediction of Zoonotic Disease
• 11344554:Pivotal Role of Dogs in Rabies Transmission, China
• 11344555:Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum
• 11344556:Francisella tularensis in the United States
• 11344557:Host Range and Emerging and Reemerging Pathogens
• 11344558:Person-to-Person Transmission of Andes Virus
• 11344559:European Bat Lyssaviruses, the Netherlands
• 11344560:Echinococcosis in Tibetan Populations, Western Sichuan Province, China
• 11344561:SARS-CoV Infection in a Restaurant from Palm Civet
• 11344562:Porcine Noroviruses Related to Human Noroviruses
• 11344563:Intergenogroup Recombination in Sapoviruses
• 11344564:Viral Load Distribution in SARS Outbreak
• 11344565:Methicillin-resistant Staphylococcus aureus in Pig Farming
• 11344566:Rabies Postexposure Prophylaxis, New York, 1995–2000
• 11344567:Pandemic Strain of Foot-and-Mouth Disease Virus Serotype O
• 11344568:Bartonella henselae in Porpoise Blood
• 11344569:Antimicrobial-drug Susceptibility of Human and Animal Salmonella Typhimurium, Minnesota, 1997–2003
• 11344570:Postepizootic Persistence of Venezuelan Equine Encephalitis Virus, Venezuela
• 11344571:Central African Hunters Exposed to Simian Immunodeficiency Virus
• 11344572:Methicillin-resistant Staphylococci in Companion Animals
• 11344573:Phocine Distemper Outbreak, the Netherlands, 2002
• 11344574:Bat Nipah Virus, Thailand
• 11344575:Cat-transmitted Sporotrichosis, Rio de Janeiro, Brazil
• 11344576:Salmonella and Campylobacter spp. in Northern Elephant Seals, California
• 11344577:Social Factors Associated with AIDS and SARS
• 11344578:African Trypanosomiasis Gambiense, Italy
• 11344579:Assays to Detect West Nile Virus in Dead Birds
• 11344580:West Nile Virus Epidemic, Northeast Ohio, 2002
• 11344581:Quarantine Stressing Voluntary Compliance
• 11344582:Bartonella quintana and Rickettsia felis in Gabon
• 11344583:Adventitious Viruses and Smallpox Vaccine
• 11344584:Fluoroquinolone Use in Food Animals
• 11344585:Ehrlichia ruminantium, Sudan
• 11344586:Borrelia spielmanii Erythema Migrans, Hungary
• 11344587:Profiling Mycobacterium ulcerans with hsp65
• 11344588:Spelling of Emerging Pathogens
• 11344589:Staphylococcus aureus Bacteremia, Europe
• 11344590:Family Clustering of Avian Influenza A(H5N1)
• 11344591:Imported Tickborne Relapsing Fever, France
• 11344592:Anaplasma phagocytophilum–infected Ticks, Japan
• 11344593:Neonatal Moraxella osloensis Ophthalmia
• 11344594:African Tick-bite Fever in French Travelers
• 11344595:Emergence of Toscana Virus in Europe
• 11344596:Highly Pathogenic Avian Influenza H5N1, Thailand, 2004
• 11344597:Coltiviruses and Seadornaviruses in North America, Europe, and Asia
• 11344598:Cervical Human Papillomavirus Screening among Older Women
• 11344599:Cryptococcus gattii in AIDS Patients, Southern California
• 11344600:Toscana Virus in Spain
• 11344601:Tickborne Pathogen Detection, Western Siberia, Russia
• 11344602:Rift Valley Fever in Small Ruminants, Senegal, 2003
• 11344603:Slow Epidemic of Lymphogranuloma Venereum L2b Strain
• 11344604:Neutralizing Antibody Response and SARS Severity
• 11344605:Norovirus Outbreaks from Drinking Water
• 11344606:Typing African Relapsing Fever Spirochetes
• 11344607:Respiratory Infections during SARS Outbreak, Hong Kong, 2003
• 11344608:Australian Public and Smallpox
• 11344609:Evaluation of West Nile Virus Education Campaign
• 11344610:Long-term Death Rates, West Nile Virus Epidemic, Israel, 2000
• 11344611:Vibrio cholerae Pathogenic Clones
• 11344612:Methicillin-resistant Staphylococcus aureus in Taiwan
• 11344613:Salmonella Paratyphi A Rates, Asia
• 11344614:Tickborne Relapsing Fever in Israel
• 11344615:Saving Lives through Global Safe Water
• 11344616:Melioidosis in Tsunami Survivors
• 11344617:Chytrid Fungus in Europe
• 11344618:Vibrio metschnikovii Pneumonia
• 11344619:Lassa Fever, Nigeria, 2003 and 2004
• 11344620:Methicillin-resistant Staphylococcus aureus Skin Infections
• 11344621:Angiostrongyliasis, Mainland China
• 11344622:Methicillin-resistant Staphylococcus aureus Necrotizing Pneumonia
• 11344623:West Nile Virus Infection and Conjunctival Exposure
• 11344624:Infections of Leisure, 3rd ed.
• 11344625:Symposium on HIV Variants and Hepatitis B Surface Antigen Mutants
• 11344626:Antimicrobial Drug Resistance: "Prediction Is Very Difficult, Especially about the Future"1
• 11344627:Emerging Foodborne Trematodiasis
• 11344628:Evolution of H5N1 Avian Influenza Viruses in Asia
• 11344629:New Measles Genotype, Uganda
• 11344630:Pyrosequencing Bacillus anthracis
• 11344631:Vancomycin and Home Health Care
• 11344632:Antibacterial Cleaning Products and Drug Resistance
• 11344633:Plasmodium falciparum Spatial Analysis, Western Kenya Highlands
• 11344634:Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry
• 11344635:Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization1
• 11344636:Methicillin-resistant Staphylococcus aureus, Western Australia
• 11344637:Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
• 11344638:Mallards and Highly Pathogenic Avian Influenza Ancestral Viruses, Northern Europe
• 11344639:Isolate Removal Methods and Methicillin-resistant Staphylococcus aureus Surveillance
• 11344640:Genetic Characterization of Nipah Virus, Bangladesh, 2004
• 11344641:Atypical Infections in Tsunami Survivors
• 11344642:Poultry-handling Practices during Avian Influenza Outbreak, Thailand
• 11344643:Anaplasma phagocytophilum in White-tailed Deer
• 11344644:Drug-resistant Escherichia coli, Rural Idaho
• 11344645:Canine Leishmaniasis, Italy
• 11344646:Myocarditis Outbreak among Adults, Illinois, 2003
• 11344647:Melioidosis in New Caledonia
• 11344648:Gastroenteritis Outbreak in British Troops, Iraq
• 11344649:Diphyllobothriasis, Brazil
• 11344650:Oropouche Virus Isolation, Southeast Brazil
• 11344651:Detecting Biological Warfare Agents
• 11344652:Rapid West Nile Virus Antigen Detection
• 11344653:Multidrug-resistant Tuberculosis Detection, Latvia
• 11344654:β-Lactam Resistance and Enterobacteriaceae, United States
• 11344655:Perinatal Group B Streptococcal Disease Prevention, Minnesota
• 11344656:Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care
• 11344657:Human Infection with Rickettsia honei, Thailand
• 11344658:West Nile Virus Antibodies in Colombian Horses
• 11344659:Syndromic Surveillance in Bioterrorist Attacks
• 11344660:Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia
• 11344661:Telithromycin-resistant Streptococcus pneumoniae
• 11344662:Integrated Human-Animal Disease Surveillance
• 11344663:VanB-VanC1 Enterococcus gallinarum, Italy
• 11344664:Empyema Thoracis from Salmonella Choleraesuis
• 11344665:Asymptomatic Yersinia pestis Infection, China
• 11344666:Canine Rabies Ecology in Southern Africa
• 11344667:Sporotrichosis, Plain of Jars, Lao People's Democratic Republic
• 11344668:Wild Poliovirus Type 1, Central African Republic
• 11344669:Achieving Operational Hydrologic Monitoring of Mosquitoborne Disease
• 11344670:Variant Creutzfeldt-Jakob Disease Death, United States
• 11344671:Dead Crow Density and West Nile Virus Monitoring, New York
• 11344672:Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire
• 11344673:Dengue Virus Type 3, Brazil, 2002
• 11344674:Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003
• 11344675:Fluoroquinolone-resistant Escherichia coli, Indonesia
• 11344676:Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin
• 11344677:Potential Impact of Antiviral Drug Use during Influenza Pandemic
• 11344678:Simulated Anthrax Attacks and Syndromic Surveillance
• 11344679:West Nile Virus–infected Mosquitoes, Louisiana, 2002
• 11344680:Legionellosis from Legionella pneumophila Serogroup 13
• 11344681:Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa
• 11344682:Human Herpesvirus 8 and Pulmonary Hypertension
• 11344683:Molecular Epidemiology of SARS-associated Coronavirus, Beijing
• 11344684:Malaria in Kenya's Western Highlands
• 11344685:Protective Behavior and West Nile Virus Risk
• 11344686:West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens
• 11344687:Endemic Tularemia, Sweden, 2003
• 11344688:West Nile Virus Isolation in Human and Mosquitoes, Mexico
• 11344689:Cyclosporiasis Outbreak, Indonesia
• 11344690:Chromobacterium violaceum in Siblings, Brazil
• 11344691:Plague from Eating Raw Camel Liver
• 11344692:Melioidosis, Northeastern Brazil
• 11344693:Gram-positive Rod Surveillance for Early Anthrax Detection
• 11344694:Multidrug-resistant Salmonella Typhimurium in Four Animal Facilities
• 11344695:Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use
• 11344696:Spoligotyping and Mycobacterium tuberculosis
• 11344697:Modeling Control Strategies of Respiratory Pathogens
• 11344698:Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
• 11344699:West Nile Virus Detection in Urine
• 11344700:Staphylococcus lugdunensis Pacemaker-related Infection
• 11344701:Bartonella quintana in Domestic Cat
• 11344702:Posttraumatic Stress after SARS
• 11344703:Evaluating Antibiograms To Monitor Drug Resistance
• 11344704:Influenza A H5N1 Detection
• 11344705:Estimating Foodborne Gastroenteritis, Australia
• 11344706:Malaria and Irrigated Crops, Accra, Ghana
• 11344707:Drug-resistant Diarrheogenic Escherichia coli, Mexico
• 11344708:Real-time Polymerase Chain Reaction To Diagnose Lymphogranuloma Venereum
• 11344709:SARS Vaccine Protective in Mice
• 11344710:Echinococcosis, Ningxia, China
• 11344711:Yersinia pestis Genotyping
• 11344712:Pandemic Vibrio parahaemolyticus O3:K6, Europe
• 11344713:Q Fever and the US Military
• 11344714:Anaplasma phagocytophilum, Sardinia, Italy
• 11344715:Williamsia muralis Pulmonary Infection
• 11344716:Optimizing Treatment of Antimicrobial-resistant Neisseria gonorrhoeae
• 11344717:Neisseria meningitidis Endotoxin and Capsule Transmission by Transplantation
• 11344718:Surveillance of Human Calicivirus in Spain
• 11344719:Epidemiology and Transmission Dynamics of West Nile Virus Disease
• 11344720:Virology, Pathology, and Clinical Manifestations of West Nile Virus Disease
• 11344721:Laboratory Exposures to Brucellae and Implications for Bioterrorism
• 11344722:Influenza A(H3N2) Outbreak, Nepal
• 11344723:Cephalosporin-resistant Pneumococci and Sickle Cell Disease
• 11344724:Methicillin-resistant Staphylococcus aureus, Hawaii, 2000–2002
• 11344725:Coxiella burnetii Genotyping
• 11344726:Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
• 11344727:Sheep Feed and Scrapie, France
• 11344728:HIV-1 Genetic Diversity in Antenatal Cohort, Canada
• 11344729:Human Coronavirus NL63, France
• 11344730:Blackwater Fever in Children, Burundi
• 11344731:Cervids as Babesiae Hosts, Slovenia
• 11344732:Salmonella Agona Outbreak from Contaminated Aniseed, Germany
• 11344733:Yersinia pseudotuberculosis Septicemia and HIV
• 11344734:Bordetella petrii Clinical Isolate
• 11344735:Hedgehog Zoonoses
• 11344736:Bartonella henselae and Domestic Cats, Jamaica
• 11344737:Pandemic Vibrio parahaemolyticus O3:K6 Spread, France
• 11344738:Third Borrelia Species in White-footed Mice
• 11344740:West Nile Virus Surveillance, Guadeloupe, 2003–2004
• 11344741:Comparing Diagnostic Coding and Laboratory Results
• 11344742:West Nile Virus Detection and Commercial Assays
• 11344743:Concurrent Dengue and Malaria
• 11344744:Hepatitis A, Italy
• 11344745:Stenotrophomonas maltophilia in Salad
• 11344746:Avian Influenza H5N1 and Healthcare Workers
• 11344747:Cell Phones and Acinetobacter Transmission
• 11344748:Attributing Illness to Food
• 11344749:Occupational Deaths among Healthcare Workers
• 11344750:Wildlife Trade and Global Disease Emergence
• 11344751:Caliciviruses and Foodborne Gastroenteritis, Chile
• 11344752:Drug-resistant Neisseria gonorrhoeae in Michigan
• 11344753:SARS Vaccine Development
• 11344754:West Nile Virus–associated Flaccid Paralysis
• 11344755:Primate-to-Human Retroviral Transmission in Asia
• 11344756:Nipah Virus in Lyle's Flying Foxes, Cambodia
• 11344757:Leptospirosis in Germany, 1962–2003
• 11344758:Survey of Tickborne Infections in Denmark
• 11344759:Influenza A H5N1 Replication Sites in Humans
• 11344760:Risk Factors for Pediatric Invasive Group A Streptococcal Disease
• 11344761:Emergency Department Response to SARS, Taiwan
• 11344762:Beliefs about Appropriate Antibacterial Therapy, California
• 11344763:Human Metapneumovirus Genetic Variability, South Africa
• 11344764:Norovirus Recombination in ORF1/ORF2 Overlap
• 11344765:Adventitious Agents and Smallpox Vaccine in Strategic National Stockpile
• 11344766:New Lymphogranuloma Venereum Chlamydia trachomatis Variant, Amsterdam
• 11344767:Household Transmission of Gastroenteritis
• 11344768:Nosocomial Malaria and Saline Flush
• 11344769:Enterotoxigenic Escherichia coli and Vibrio cholerae Diarrhea, Bangladesh, 2004
• 11344770:SARS Coronavirus Detection Methods
• 11344771:Veillonella montpellierensis Endocarditis
• 11344772:Burkholderia fungorum Septicemia
• 11344773:Asymptomatic SARS Coronavirus Infection among Healthcare Workers, Singapore
• 11344774:Clinician Knowledge and Beliefs after Statewide Program to Promote Appropriate Antimicrobial Drug Use
• 11344775:Community Prescribing and Resistant Streptococcus pneumoniae
• 11344776:Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
• 11344777:Free-living Canada Geese and Antimicrobial Resistance
• 11344778:Macrolide- and Telithromycin-resistant Streptococcus pyogenes, Belgium, 1999–20031
• 11344779:Hospitalization and Antimicrobial Resistance in Salmonella Outbreaks, 1984–2002
• 11344780:Rifampicin Resistance in Tuberculosis Outbreak, London, England
• 11344781:Tuberculosis due to Resistant Haarlem Strain, Tunisia
• 11344782:Community-acquired Methicillin-resistant Staphylococcus aureus, Uruguay
• 11344783:Community-associated Methicillin-resistant Staphylococcus aureus, Switzerland
• 11344784:Community-associated Methicillin-resistant Staphylococcus aureus in Pediatric Patients
• 11344785:Erythromycin-nonsusceptible Streptococcus pneumoniae in Children, 1999–2001
• 11344786:Rifampin-resistant Meningococcal Disease
• 11344787:Diversification in Salmonella Typhimurium DT104
• 11344788:Extended-spectrum β-Lactamase-producing Flora in Healthy Persons
• 11344789:Cephalosporin and Ciprofloxacin Resistance in Salmonella, Taiwan
• 11344790:Measuring Impact of Antimicrobial Resistance
• 11344791:Antimicrobial Resistance in Campylobacter
• 11344792:Quinolone Safety and Efficacy
• 11344793:An Emptying Quiver: Antimicrobial Drugs and Resistance
• 11344794:Antimicrobial Resistance Determinants and Future Control
• 11344795:Hidden Epidemic of Macrolide-resistant Pneumococci
• 11344796:Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs
• 11344797:Nonprescribed Antimicrobial Drugs in Latino Community, South Carolina
• 11344798:Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units
• 11344799:Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States
• 11344800:Global Spread of Multiple Aminoglycoside Resistance Genes
• 11344801:Relative Fitness of Fluoroquinolone-resistant Streptococcus pneumoniae
• 11344802:Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
• 11344803:Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States
• 11344804:International Salmonella Typhimurium DT104 Infections, 1992–2001
• 11344805:Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance
• 11344806:pVir and Bloody Diarrhea in Campylobacter jejuni Enteritis
• 11344807:Impact of Statewide Program To Promote Appropriate Antimicrobial Drug Use
• 11344808:Community-associated Methicillin-resistant Staphylococcus aureus, Canada
• 11344809:Trypanosomiasis Relapse after Melarsoprol Therapy, Democratic Republic of Congo, 1982–2001
• 11344810:Fluoroquinolone-resistant Escherichia coli Carriage in Long-Term Care Facility
• 11344811:armA and Aminoglycoside Resistance in Escherichia coli
• 11344812:More Dengue, More Questions
• 11344813:Dengue Fever, Hawaii, 2001–2002
• 11344814:Dengue Risk among Visitors to Hawaii during an Outbreak
• 11344815:Dengue Type 3 Virus, Saint Martin, 2003–2004
• 11344816:Dengue Antibody Prevalence in German Travelers
• 11344817:Leptospirosis during Dengue Outbreak, Bangladesh
• 11344818:Barriers to Creutzfeldt-Jakob Disease Autopsies, California
• 11344819:Q Fever Wildlife Reservoir
• 11344820:Vaccine–derived Poliovirus, Thailand, 2003
• 11344821:Toscana Virus and Acute Meningitis, France
• 11344822:Helicobacter pylori, Republic of Georgia
• 11344823:Botulism and Preserved Green Olives
• 11344824:Retinal Hemorrhages in 4 Patients with Dengue Fever
• 11344825:Venezuelan Equine Encephalitis Virus Infection of Spiny Rats
• 11344826:Risk Factors for Kala-Azar in Bangladesh
• 11344827:Avian Influenza Risk Perception, Hong Kong
• 11344828:Assessing Parents' Perception of Children's Risk for Recreational Water Illnesses
• 11344829:Adenovirus Type 7 Peptide Diversity during Outbreak, Korea, 1995–2000
• 11344830:Osler and the Infected Letter
• 11344831:Low Diversity of Alkhurma Hemorrhagic Fever Virus, Saudi Arabia, 1994–1999
• 11344832:Highly Pathogenic H5N1 Influenza Virus in Smuggled Thai Eagles, Belgium
• 11344833:Salmonella Derby Clonal Spread from Pork
• 11344834:Probable Tiger-to-Tiger Transmission of Avian Influenza H5N1
• 11344835:Dengue Virus Type 3, Cuba, 2000–2002
• 11344836:Human T-cell Leukemia Virus Type 1 Molecular Variants, Vanuatu, Melanesia
• 11344837:Incident Tuberculosis among Recent US Immigrants and Exogenous Reinfection
• 11344838:Antibody Testing and Lyme Disease Risk
• 11344839:Emergency Survey Methods in Acute Cryptosporidiosis Outbreak
• 11344840:Travel-associated Rabies in Austrian Man
• 11344841:Media Effects on Students during SARS Outbreak
• 11344842:Clonal Comparison of Staphylococcus aureus Isolates from Healthy Pig Farmers, Human Controls, and Pigs
• 11344843:Human Pythiosis, Brazil
• 11344844:Are Noroviruses Emerging
• 11344845:Persistent Emergence of Dengue
• 11344846:Nosocomial Dengue by Mucocutaneous Transmission
• 11344847:Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland
• 11344848:Tuberculosis Elimination in the Netherlands
• 11344849:Web-based Investigation of Multistate Salmonellosis Outbreak
• 11344850:Mycobacteria in Nail Salon Whirlpool Footbaths, California
• 11344851:Coxiella burnetii in Bulk Tank Milk Samples, United States
• 11344852:Human Spotted Fever Rickettsial Infections
• 11344853:Patient Contact Recall after SARS Exposure
• 11344854:Tickborne Meningoencephalitis, First Case after 19 Years in Northeastern Germany
• 11344855:Social Impact of Leishmaniasis, Afghanistan
• 11344856:Methicillin-resistant Staphylococcus aureus Toxic Shock Syndrome
• 11344857:Are SARS Superspreaders Cloud Adults
• 11344858:Route of Infection in Melioidosis
• 11344859:Bordetella pertussis in Adult Pneumonia Patients1
• 11344860:SARS Risk Perception and Preventive Measures, Singapore and Japan
• 11344861:Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases
• 11344862:Recurring Methicillin-resistant Staphylococcus aureus Infections in a Football Team
• 11344863:Ross River Virus Disease Reemergence, Fiji, 2003–2004
• 11344864:Antimicrobial-resistant Invasive Escherichia coli, Spain
• 11344865:Staphylococcus aureus Bacteremia, Australia
• 11344866:Echovirus 30, Jiangsu Province, China
• 11344867:Experimental Infection of Prairie Dogs with Monkeypox Virus
• 11344868:Reemergence of Canine Echinococcus granulosus Infection, Wales
• 11344869:Bed Bug Infestations in an Urban Environment
• 11344870:European Bat Lyssavirus in Scottish Bats
• 11344871:Influenza Outbreak Control in Confined Settings
• 11344872:Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002
• 11344873:Buruli Ulcer Recurrence, Benin
• 11344874:Molecular Mechanisms of West Nile Virus Pathogenesis in Brain Cells
• 11344875:Japanese Encephalitis Virus in Meningitis Patients, Japan
• 11344876:Identifying Relapsing Fever Borrelia, Senegal
• 11344877:Babesia microti, Upstate New York
• 11344878:Pythiosis in Africa
• 11344879:Hepatitis E Infections, Victoria, Australia
• 11344880:Emerging Infectious Diseases: 10 Years Running
• 11344882:Malaria and Travel to the Dominican Republic
• 11344883:Endogeneity in Logistic Regression Models
• 11344884:Buruli Ulcer Distribution in Benin
• 11344885:Mycobacterium tuberculosis Drug Resistance, Abkhazia
• 11344886:Rectal Lymphogranuloma Venereum, France
• 11344887:Pertussis in Soldiers, Israel
• 11344888:Food Safety for First Responders
• 11344889:Rickettsiae in Ixodid Ticks, Sicily
• 11344890:Fly Transmission of Campylobacter
• 11344891:Rats, Lice, and Zinsser
• 11344892:Disease Risks from Foods, England and Wales, 1996–2000
• 11344893:Probable Psittacosis Outbreak Linked to Wild Birds
• 11344894:Rapid Identification of Emerging Pathogens: Coronavirus
• 11344895:Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care
• 11344896:Effect of Regulation and Education on Reptile-associated Salmonellosis
• 11344897:SARS Risk Perceptions in Healthcare Workers, Japan
• 11344898:Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
• 11344899:Ebola Virus Antibody Prevalence in Dogs and Human Risk
• 11344900:SARS-related Perceptions in Hong Kong
• 11344901:West Nile Virus Risk Assessment and the Bridge Vector Paradigm
• 11344902:Concomitant Tickborne Encephalitis and Human Granulocytic Ehrlichiosis
• 11344903:Methicillin-resistant Staphylococcus aureus in Horses and Horse Personnel, 2000–2002
• 11344904:Malaria Risk in Travelers
• 11344905:Notifiable Disease Surveillance and Practicing Physicians
• 11344906:Rumor Surveillance and Avian Influenza H5N1
• 11344907:SARS-associated Coronavirus Transmitted from Human to Pig
• 11344908:Methicillin-resistant Staphylococcus aureus in Neonatal Intensive Care Unit
• 11344909:Inquilinus limosus in Patients with Cystic Fibrosis, Germany
• 11344910:Fever Screening at Airports and Imported Dengue
• 11344911:Mimivirus in Pneumonia Patients
• 11344912:Human Metapneumovirus RNA in Encephalitis Patient
• 11344913:Noroviruses in Archival Samples
• 11344914:Sporadic Cryptosporidiosis Decline after Membrane Filtration of Public Water Supplies, England, 1996–2002
• 11344915:Pneumocystis jirovecii in General Population
• 11344916:Spotted Fever Group and Typhus Group Rickettsioses in Humans, South Korea
• 11344917:Bacterial Zoonoses and Infective Endocarditis, Algeria
• 11344918:Survey for Bat Lyssaviruses, Thailand
• 11344919:Novel Flavivirus or New Lineage of West Nile Virus, Central Europe
• 11344920:First Self
• 11344921:Schistosoma mansoni in Family 5 Years after Safari
• 11344922:Community-associated Methicillin-resistant Staphylococcus aureus, Singapore
• 11344923:Mumps Virus–associated Hemophagocytic Syndrome
• 11344924:Imported Cutaneous Diphtheria, Germany, 1997–2003
• 11344925:Antimicrobial Drug Consumption in Companion Animals
• 11344926:Vibrio cholerae SXT Element, Laos
• 11344927:Lack of H5N1 Avian Influenza Transmission to Hospital Employees, Hanoi, 2004
• 11344928:Modeling the Impact of Pandemic Influenza on Pacific Islands
• 11344929:Mycotic Brain Abscess Caused by Opportunistic Reptile Pathogen
• 11344930:Tuberculosis in Undocumented Migrants, Geneva
• 11344931:Mycobacterium chelonae Skin Infection in Kidney-Pancreas Recipient
• 11344932:SARS Control and Psychological Effects of Quarantine, Toronto, Canada
• 11344933:Diagnostic System for Rapid and Sensitive Differential Detection of Pathogens
• 11344934:West Nile Virus in Morocco, 2003
• 11344935:Bat Incidents at Children's Camps, New York State, 1998–2002
• 11344936:Molecular Evidence of Pneumocystis Transmission in Pediatric Transplant Unit
• 11344937:Bacteremic Typhoid Fever in Children in an Urban Slum, Bangladesh
• 11344938:Human Disease from Influenza A(H5N1), Thailand, 2004
• 11344939:Late Recognition of SARS in Nosocomial Outbreak, Toronto
• 11344940:Malaria Epidemic and Drug Resistance, Djibouti
• 11344941:Comparing Aberration Detection Methods with Simulated Data
• 11344942:In Vitro Host-Cell Susceptibility to Usutu Virus
• 11344943:Surveillance and Control Measures during Smallpox Outbreaks
• 11344944:Quarantine for SARS, Taiwan
• 11344945:Wild Animal Mortality Monitoring and Human Ebola Outbreaks, Gabon and Republic of Congo, 2001–2003
• 11344946:Isolation of Waddlia malaysiensis, A Novel Intracellular Bacterium, from Fruit Bat(Eonycteris spelaea)
• 11344947:Rickettsial Infection in Animals and Brazilian Spotted Fever Endemicity
• 11344948:Carbapenemase-producing Enterobacteriaceae, U.S. Rivers
• 11344949:Managing Febrile Respiratory Illnesses during a Hypothetical SARS Outbreak
• 11344950:Hybrid Vibrio vulnificus
• 11344951:Dengue and Dengue Hemorrhagic Fever, Brazil, 1981–2002
• 11344952:Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase Type
• 11344953:Mycobacterium haemophilum and Lymphadenitis in Children
• 11344954:HEPA/Vaccine Plan for Indoor Anthrax Remediation
• 11344957:卫生监督执法过错将被追究责任
• 11344958:中美科学家找到白血病抑制基因
• 11344962:镇沅专项检查流通环节医疗器械质量
• 11344972:李勇入选感动甘肃十大新闻人物
• 11344973:药品监管驶入信息高速路
• 11344975:吴仪在2007年全国中医药工作会议上强调——坚定不移地发展中医药事业
• 11344981:案件终结后还需“再回头”
• 11344983:对药监行政处罚自由裁量权约束的探索
• 11344984:生产环节药品质量究竟该由谁把关
• 11344989:销售食药两用产品致人中毒做何处理
• 11344990:法人合并后违法主体如何确定
• 11344992:合法行使行政检查权
• 11344993:行政相对人逃避检查，怎么办？
• 11344994:盐酸倍他司汀口服液疗效值得信赖
• 11344995:墨西哥发明抗癌“特洛伊木马”
• 11344996:首批人类生殖技术培训基地获批
• 11344998:美女美在骨头里——记“中国美貌人群颅面骨三维测量数据库”主创者张海钟
• 11344999:技术水平低 医疗设备差——我国个体牙科诊所现状堪忧

页面最后生成日期：2012/10/30 18:48:03